Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 4Colorectal Neoplasms 3Rectal Neoplasms 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Neoadjuvant Therapy 1Hyperthermia 1Biliary Tract Neoplasms 1Adenocarcinoma of the Lower Rectum 1

Interventions

Self Expandable Metallic Stents 3Gemcitabine 2Dietary Supplements 2surufatinib 1durvalumab 1Yoga 1Whey Proteins 1Walking 1Trace Elements 1Saline Solution 1Radiofrequency Ablation 1Poly(ADP-ribose) Polymerase Inhibitors 1Pancreaticojejunostomy 1Immune Checkpoint Inhibitors 1Folfox protocol 1Exercise 1Ethanol 1Duodenoscopes 1Congresses as Topic 1Cisplatin 1Cholangiopancreatography, Endoscopic Retrograde 1Catheter Ablation 1Capecitabine 1Blood Specimen Collection 1Bevacizumab 1Anti-Bacterial Agents 1Anesthesia, Local 1Actigraphy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Biliary Tract Neoplasms × Folfox protocol × Clear all
NCT07466238 2026-05-08

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Peking University

Phase NA Recruiting
40 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡